Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lavine

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Science Translational Medicine|May 10, 2023
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruptionElmira Esmaeilzadeh, Behzad Etemad, Christy L Lavine, et al.
Nature Microbiology|May 11, 2026
Diverse paths to broadly neutralizing antibody escape among HIV-1 strainsAlex C Stabell, Songhee Lee, Debby J Park, et al.
Virology|November 20, 2009
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Avishek Nandi, Christine L Lavine, Pengcheng Wang, et al.
Journal of Virology|December 5, 2014
Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocksHui-Wen Chang, Lawrence J Tartaglia, James B Whitney, et al.
Journal of Virology|December 1, 2022
Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C InfectionTawanda Mandizvo, Nombali Gumede, Bongiwe Ndlovu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2020
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruptionViviane M Andrade, Carla Mavian, Dunja Babic, et al.
EMBO Reports|January 26, 2024
Antibody-mediated SARS-CoV-2 entry in cultured cellsMd Golam Kibria, Christy L Lavine, Weichun Tang, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Nature Structural & Molecular Biology|January 12, 2021
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agentTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 24, 2021
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variantJun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Science Translational Medicine|May 10, 2023
Autologous neutralizing antibodies increase with early antiretroviral therapy and shape HIV rebound after treatment interruptionElmira Esmaeilzadeh, Behzad Etemad, Christy L Lavine, et al.
Nature Microbiology|May 11, 2026
Diverse paths to broadly neutralizing antibody escape among HIV-1 strainsAlex C Stabell, Songhee Lee, Debby J Park, et al.
Virology|November 20, 2009
Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1Avishek Nandi, Christine L Lavine, Pengcheng Wang, et al.
Journal of Virology|December 5, 2014
Generation and evaluation of clade C simian-human immunodeficiency virus challenge stocksHui-Wen Chang, Lawrence J Tartaglia, James B Whitney, et al.
Journal of Virology|December 1, 2022
Subtle Longitudinal Alterations in Env Sequence Potentiate Differences in Sensitivity to Broadly Neutralizing Antibodies following Acute HIV-1 Subtype C InfectionTawanda Mandizvo, Nombali Gumede, Bongiwe Ndlovu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 18, 2020
A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruptionViviane M Andrade, Carla Mavian, Dunja Babic, et al.
EMBO Reports|January 26, 2024
Antibody-mediated SARS-CoV-2 entry in cultured cellsMd Golam Kibria, Christy L Lavine, Weichun Tang, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2020
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Nature Structural & Molecular Biology|January 12, 2021
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agentTianshu Xiao, Jianming Lu, Jun Zhang, et al.
Biorxiv : the Preprint Server for Biology|August 24, 2021
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variantJun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Pageof 7